ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 45 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $182,000 | +24.7% | 17,013 | 0.0% | 0.08% | +20.6% |
| Q2 2021 | $146,000 | -18.9% | 17,013 | 0.0% | 0.06% | -12.5% |
| Q1 2021 | $180,000 | -15.9% | 17,013 | 0.0% | 0.07% | -25.8% |
| Q4 2020 | $214,000 | +42.7% | 17,013 | 0.0% | 0.10% | +3.2% |
| Q3 2020 | $150,000 | +54.6% | 17,013 | +70.1% | 0.09% | +49.2% |
| Q2 2020 | $97,000 | +234.5% | 10,000 | 0.0% | 0.06% | +186.4% |
| Q1 2020 | $29,000 | -23.7% | 10,000 | 0.0% | 0.02% | -4.3% |
| Q4 2019 | $38,000 | -5.0% | 10,000 | 0.0% | 0.02% | -14.8% |
| Q3 2019 | $40,000 | -4.8% | 10,000 | 0.0% | 0.03% | -3.6% |
| Q2 2019 | $42,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 2,571,450 | $32,400,000 | 2.50% |
| Omega Fund Management, LLC | 1,284,900 | $16,190,000 | 2.43% |
| Avidity Partners Management LP | 1,248,000 | $15,725,000 | 0.51% |
| Samsara BioCapital, LLC | 399,190 | $5,030,000 | 0.51% |
| EcoR1 Capital, LLC | 741,290 | $9,340,000 | 0.50% |
| DAFNA Capital Management LLC | 113,202 | $1,426,000 | 0.42% |
| TIGER MANAGEMENT L.L.C. | 137,728 | $1,735,000 | 0.39% |
| Orbimed Advisors | 3,070,955 | $38,694,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 198,260 | $2,498,000 | 0.22% |
| Artal Group S.A. | 593,030 | $7,472,000 | 0.16% |